Study of Acupuncture Alleviating Pain of Cancer Patients with Intrathecal Drug Administration

Efficacy and Safety Study of Acupuncture on Patients with Severe Cancer Pain Controlling with Intrathecal Drug Administration

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000818

Enrollment

Registered

2013-08-12

Start date

2013-08-19

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device, Procedure/Surgery : This is a piolt study to investigate the efficacy of acupuncture comparing acupuncture plus intrathecal drug administration with intrathecal administration alone. A

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Cancer-related pain 2. no problem with expression and concentration of language 3. subjects capable of monitoring follow-up during trial 4. voluntary participation and sign of informed consent 5. life expentancy of 1 month or more 6. VAS scores of 5 or more despite oral intake of 200mg/d morphine 7. no response of conservative therapy or impossilbe to increase opioid dose owing to severe adverse events 8. possibility of delayed pain due to cancer, which diagnosed by histological or cytological examination 9. No mechanical barrier of tissue, good flow of cerebrospinal fluid (CSF), no active infection for set-up of pain-relief instrument

Exclusion criteria

Exclusion criteria: 1. coagulopahty 2. severe hepatic or renal dysfuction (AST or AST value over 100 IU/L, Creatinine value over 3.4mg%) 3. cognitive impairment making prompt response and evaluation impossible 4. pregnant, lactoaging, or fertile women with no consent of proper contraception 5. no sign of informed consent 6. hypersensitive with local anesthetics or opioid 7. acute infection 8. history of alcohol or drug abuse 9. aucte or self control pain 10. cancer blocking spinal canal 11. respiratory failure

Design outcomes

Primary

Measure	Time frame
Visual analogue severity (VAS) scale;Pain vision	—

Secondary

Measure	Time frame
analgesic requirment ;Functional Assessment Cancer Therapy-General (FACT-G)	—

Countries

Korea, Republic of

Contacts

Public ContactWoon-Seok Roh

Daegu Catholic Univercity Medical Center

Outcome results